Apollo Hospitals Enterprise Limited
APOLLOHOSP
Rank in Stocks
#1776
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
Share Price
$83.84
Market Cap
$12.05B
Change (1 day)
-1.34%
Change (1 year)
-7.89%
Country
IN
Trade Apollo Hospitals Enterprise Limited (APOLLOHOSP)
Category
Healthcare
P/E ratio for Apollo Hospitals Enterprise Limited (APOLLOHOSP)
P/E ratio as of October 2026 TTM: 54.65
According to Apollo Hospitals Enterprise Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 54.65. At the end of 2024 the company had a P/E ratio of 103.32.
P/E ratio history for Apollo Hospitals Enterprise Limited from 2005 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 54.65 | -17.13% |
| 2025 | 65.95 | -36.17% |
| 2024 | 103.32 | 36.54% |
| 2023 | 75.67 | 23.02% |
| 2022 | 61.51 | -77.23% |
| 2021 | 270.18 | 675.57% |
| 2020 | 34.84 | -53.44% |
| 2019 | 74.82 | -42.50% |
| 2018 | 130.12 | 77.39% |
| 2017 | 73.35 | 28.30% |
| 2016 | 57.17 | -0.79% |
| 2015 | 57.63 | 38.45% |
| 2014 | 41.62 | 7.29% |
| 2013 | 38.80 | -1.09% |
| 2012 | 39.22 | 17.57% |
| 2011 | 33.36 | -0.96% |
| 2010 | 33.68 | 26.51% |
| 2009 | 26.63 | -18.22% |
| 2008 | 32.56 | 15.08% |
| 2007 | 28.29 | -44.09% |
| 2006 | 50.60 | 26.17% |
| 2005 | 40.10 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 15.70 | -71.27% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -80.97% |
US
|
|
| 32.07 | -41.32% |
SA
|
|
| 20.00 | -63.40% |
BR
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.